Characterization, sequencing and comparative genomic analysis of vB-AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Peng, Fan ^a,b,c   Mi, Zhiqiang ^a   Huang, Yong ^a   Yuan, Xin ^b   Niu, Wenkai ^b   Wang, Yahui ^a   Hua, Yuhui ^a   Fan, Huahao ^a   Bai, Changqing ^b   Tong, Yigang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b The 307 PLA Hospital   (China)

^c THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; Bacteriophage; Characteristics; Genome

Indexed keywords

AMPICILLIN; AZTREONAM; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CIPROFLOXACIN; COTRIMOXAZOLE; DOUBLE STRANDED DNA; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NITROFURANTOIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN; STRUCTURAL PROTEIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADSORPTION; ARTICLE; BACTERIOPHAGE; BACTERIUM ISOLATE; DNA SEQUENCE; GENE SEQUENCE; GENOME; GENOMICS; HOST CELL; LATENT PERIOD; MOLECULAR WEIGHT; NONHUMAN; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIOPHAGE VB ABAM IME AB2; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; MICROBIAL DIVERSITY; MINIMUM INHIBITORY CONCENTRATION; MYOVIRIDAE; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY; SEQUENCE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; VIRUS ISOLATION;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); MYOVIRIDAE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIOPHAGES; DNA VIRUSES; DNA, VIRAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENOME, VIRAL; HUMANS; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MYOVIRIDAE; SEQUENCE ANALYSIS, DNA; VIRAL PLAQUE ASSAY; VIRAL PROTEINS; VIRUS ATTACHMENT;

EID: 84908101993     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-14-181     Document Type: Article

References (49)

1. Global challenge of multidrug-resistant Acinetobacter baumannii. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA, Antimicrobial agents and chemotherapy 2007 51 10 3471 3484 (Pubitemid 47519332)
2. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Falagas ME, Karageorgopoulos DE, Clinical infectious diseases 2008 46 7 1121 1122 (Pubitemid 351589881)
3. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. Falagas ME, Koletsi PK, Bliziotis IA, Journal of medical microbiology 2006 55 12 1619 1629 (Pubitemid 44902023)
4. Acinetobacter baumannii: emergence of a successful pathogen. Peleg AY, Seifert H, Paterson DL, Clinical microbiology reviews 2008 21 3 538 582
5. Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. Jin J, Li ZJ, Wang SW, Wang SM, Huang DH, Li YH, Ma YY, Wang J, Liu F, Chen XD, BMC microbiology 2012 12 1 156
6. Bacteriophage therapy. Sulakvelidze A, Alavidze Z, Morris JG, Antimicrobial agents and chemotherapy 2001 45 3 649 659 (Pubitemid 32182003)
7. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. Ryan EM, Gorman SP, Donnelly RF, Gilmore BF, Journal of Pharmacy and Pharmacology 2011 63 10 1253 1264
8. Position paper: the creation of a rational scheme for the nomenclature of viruses of Bacteria and Archaea. Kropinski AM, Prangishvili D, Lavigne R, Environmental microbiology 2009 11 11 2775 2777
9. Isolation and characterization of a bacteriophage F20 virulent to Enterobacter aerogenes. Mishra CK, Choi TJ, Kang SC, J Gen Virol 2012 93 Pt 10 2310 2314
10. Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin. Zhang W, Mi Z, Yin X, Fan H, An X, Zhang Z, Chen J, Tong Y, PLoS ONE 2013 8 11 80435
11. Bacteriophage burst size during multiple infections. Gadagkar R, Gopinathan K, Journal of Biosciences 1980 2 3 253 259
12. Vector NTI, a balanced all-in-one sequence analysis suite. Lu G, Moriyama EN, Briefings in bioinformatics 2004 5 4 378 388
13. Sequence characteristics of T4-like bacteriophage IME08 benome termini revealed by high throughput sequencing. Jiang X, Jiang H, Li C, Wang S, Mi Z, An X, Chen J, Tong Y, Virology Journal 2011 8 1 194
14. Evidence of a dominant lineage of Vibrio cholerae-specific lytic bacteriophages shed by cholera patients over a 10-year period in Dhaka, Bangladesh. Seed KD, Bodi KL, Kropinski AM, Ackermann HW, Calderwood SB, Qadri F, Camilli A, MBio 2011 2 1 00334 00310
15. Cobalt Stress in Escherichia coli THE EFFECT ON THE IRON-SULFUR PROTEINS. Ranquet C, Ollagnier-de-Choudens S, Loiseau L, Barras F, Fontecave M, Journal of Biological Chemistry 2007 282 42 30442 30451 (Pubitemid 350035171)
16. Information theory based T7-like promoter models: classification of bacteriophages and differential evolution of promoters and their polymerases. Chen Z, Schneider TD, Nucleic acids research 2005 33 19 6172 6187 (Pubitemid 41742555)
17. The many faces of the helix-turn-helix domain: transcription regulation and beyond. Aravind L, Anantharaman V, Balaji S, Babu MM, Iyer LM, FEMS microbiology reviews 2005 29 2 231 262 (Pubitemid 40439243)
18. CRISPR-a widespread system that provides acquired resistance against phages in bacteria and archaea. Sorek R, Kunin V, Hugenholtz P, Nature Reviews Microbiology 2008 6 3 181 186 (Pubitemid 351256313)
19. The immunity (imm) gene of Escherichia coli bacteriophage T4. Lu MJ, Henning U, Journal of virology 1989 63 8 3472 3478 (Pubitemid 19181409)
20. Analysis of capsid portal protein and terminase functional domains: interaction sites required for DNA packaging in bacteriophage T4. Lin H, Rao VB, Black LW, Journal of molecular biology 1999 289 2 249 260 (Pubitemid 29278380)
21. Phage therapy-advantages over antibiotics? Pirisi A, The Lancet 2000 356 9239 1418
22. Phage treatment of human infections. Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM, Bacteriophage 2011 1 2 66 85
23. Bacteriophages show promise as antimicrobial agents. Alisky J, Iczkowski K, Rapoport A, Troitsky N, Journal of Infection 1998 36 1 5 15 (Pubitemid 128645619)
24. Bacteriophage therapy for infections in cancer patients. Weber-Dabrowska B, Mulczyk M, Górski A, Clinical and Applied Immunology Reviews 2001 1 3 131 134
25. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, Glonti T, Krylov V, Mast J, Van Parys L, PLoS One 2009 4 3 4944
26. Host range and lytic capability of four bacteriophages against bovine and clinical human isolates of Shiga toxinproducing Escherichia coli O157: H7. Niu Y, Johnson R, Xu Y, McAllister T, Sharma R, Louie M, Stanford K, Journal of applied microbiology 2009 107 2 646 656
27. Isolation of Bacteriophage against Currently Circulating Strains of Acinetobacter baumannii. Jane FT, Claire P, Matthew JH, Journal of Medical Microbiology & Diagnosis 2012 1 109
28. Genomes of the T4-related bacteriophages as windows on microbial genome evolution. Vasiliy P, Swarnamala R, James N, Jim K, Virology Journal 2010 7 292
29. Genomic analysis of bacteriophage φAB1, a φKMV-like virus infecting multidrug-resistant. Acinetobacter baumannii. Chang KC, Lin NT, Hu A, Lin YS, Chen LK, Lai MJ, Genomics 2011 97 4 249 255
30. Complete Genome Sequence of the Podoviral Bacteriophage YMC/09/02/B1251 ABA BP, Which Causes the Lysis of an OXA-23-Producing Carbapenem-Resistant Acinetobacter baumannii Isolate from a Septic Patient. Jeon J, Kim J, Yong D, Lee K, Chong Y, Journal of virology 2012 86 22 12437 12438
31. Selection for bacteriophage latent period length by bacterial density: a theoretical examination. Abedon ST, Microbial Ecology 1989 18 2 79 88 (Pubitemid 19253378)
32. Bioinformatic analysis of the Acinetobacter baumannii phage AB1 genome. Li P, Chen B, Song Z, Song Y, Yang Y, Ma P, Wang H, Ying J, Ren P, Yang L, Gene 2012 507 2 125 134
33. Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii. Popova AV, Zhilenkov EL, Myakinina VP, Krasilnikova VM, Volozhantsev NV, FEMS microbiology letters 2012 332 1 40 46
34. Complete Genome Sequence of Bacteriophage phiAC-1 Infecting Acinetobacter soli Strain KZ-1. Kim JH, Oh C, Choresca CH, Shin SP, Han JE, Jun JW, Heo S-J, Kang D-H, Park SC, Journal of virology 2012 86 23 13131 13132
35. Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm. Thawal ND, Yele AB, Sahu PK, Chopade BA, Current microbiology 2012 65 1 66 72
36. Novel lytic bacteriophage AB7-IBB1 of Acinetobacter baumannii: isolation, characterization and its effect on biofilm. Yele AB, Thawal ND, Sahu PK, Chopade BA, Archives of virology 2012 157 8 1441 1450
37. Characterization and Genome Sequencing of Phage Abp1, a New phiKMV-Like Virus Infecting Multidrug-Resistant Acinetobacter baumannii. Huang G, Le S, Peng Y, Zhao Y, Yin S, Zhang L, Yao X, Tan Y, Li M, Hu F, Current microbiology 2013 66 6 535 543
38. Sequencing and bioinformatic analysis of genome of Acinetobacter baumannii bacteriophage AB3. Jie Z, Xi L, Dan G, Journal of Third Military Medical University 2013 15 008
39. Isolation and Characterization of km18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii. Shen G-H, Wang J-L, Wen F-S, Chang K-M, Kuo C-F, Lin C-H, Luo H-R, Hung C-H, PloS one 2012 7 10 46537
40. Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2. Lee C-N, Tseng T-T, Lin J-W, Fu Y-C, Weng S-F, Tseng Y-H, Applied and environmental microbiology 2011 77 19 6755 6762
41. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. Yang H, Liang L, Lin S, Jia S, BMC microbiology 2010 10 1 131
42. Isolation and characterization of AB2: a novel bacteriophage of Acinetobacter baumannii. Lin N-T, Chiou P-Y, Chang K-C, Chen L-K, Lai M-J, Research in microbiology 2010 161 4 308 314
43. Ensifer adhaerens predatory activity against other bacteria in soil, as monitored by indirect phage analysis. Germida JJ, Casida L Jr, Applied and Environmental Microbiology 1983 45 4 1380 1388 (Pubitemid 13132972)
44. Adams MH, Comroe JH, Venning E, Methods of Study of Bacterial Viruses Year Book Publishers 1950
45. Characterization of the Salmonella bacteriophage vB-SenS-Ent1. Turner D, Hezwani M, Nelson S, Salisbury V, Reynolds D, J Gen Virol 2012 93 Pt 9 2046 2056
46. Practical procedures for the purification of bacterial viruses. Bachrach U, Friedmann A, Appl Microbiol 1971 22 4 706 715
47. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Zerbino DR, Birney E, Genome research 2008 18 5 821 829 (Pubitemid 351645072)
48. The RAST Server: rapid annotations using subsystems technology. Aziz R, Bartels D, Best A, DeJongh M, Disz T, Edwards R, Formsma K, Gerdes S, Glass E, Kubal M, BMC genomics 2008 9 1 75
49. The InterPro database and tools for protein domain analysis. Mulder NJ, Apweiler R, Current protocols in bioinformatics 2008 2.7 1-2.7. 18